Nghiên cứu đặc điểm điện sinh lý tim và kết quả điều trị cơn rung nhĩ kịch phát bằng năng lượng sóng có tần số radio - 23

70. Isabelle N., Miyazaki S., Forclaz A., et al. (2010), "Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation", Euro Heart Journal, 31, pp. 1046 ­ 1054.

71. Jais P., Cauchemez B., Macle L., et al. (2008), "Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study", Circulation, 118, pp. 2498 ­ 2505.

72. Jais P., Hocini M., Macle L., et al. (2002), "Distinctive electro­ physiological properties of pulmonary veins in patients with atrial fibrillation", Circulation, 106(19), pp. 2479 ­ 2485.

73. James P., Oparil S., Carter B., et al. (2014), "2014 Evidence­Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)", JAMA, 311(5), pp. 507 ­ 520.

74. Jongnarangsin K., Suwanagool A., Chugh A., et al. (2012), "Effect of catheter ablation on progression of paroxysmal atrial fibrillation", Journal of cardiovascular electrophysiology, 23(1), pp. 9 ­ 14.

75. Jons C., Hansen P., Johannessen A. et al. (2009), "The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA­PAF) trial: clinical rationale, study design, and implementation.", Europace, 11(7), pp. 917 ­ 923.

76. Khan M., Jais P., Cummings J., et al. (2008), "Pulmonary­vein isolation for atrial fibrillation in patients with heart failure", N Engl J Med, 359, pp. 1778 ­ 1785.

77. Khaykin Y., Marrouche N., Martin D., et al. (2004), "Pulmonary vein isolation for atrial fibrillation in patients with symptomatic sinus bradycardia or pauses.", J Cardiovasc Electrophysiol, 15(7), pp. 784 ­

Có thể bạn quan tâm!

• Sơ Đồ Một Số Đường Triệt Đốt Trong Nhĩ Trái
• Đặc Điểm Điện Sinh Lý Tim Ở Bệnh Nhân Rung Nhĩ Kịch Phát
• Nghiên cứu đặc điểm điện sinh lý tim và kết quả điều trị cơn rung nhĩ kịch phát bằng năng lượng sóng có tần số radio - 22
• Trần Văn Đồng (2006), Nghiên Cứu Điện Sinh Lý Tim Và Điều Trị Hội Chứng Wolff ­ Parkinson ­ White Bằng Năng Lượng Sóng Có Tần Số Radio, Luận Án Tiến Sĩ Y
• Nghiên cứu đặc điểm điện sinh lý tim và kết quả điều trị cơn rung nhĩ kịch phát bằng năng lượng sóng có tần số radio - 25
• Nghiên cứu đặc điểm điện sinh lý tim và kết quả điều trị cơn rung nhĩ kịch phát bằng năng lượng sóng có tần số radio - 26

Xem toàn bộ 224 trang tài liệu này.

789.

78. Khaykin Y., Wang X., Natale A., et al. (2009), "Cost comparison of ablation versus antiarrhythmic drugs as first­line therapy for atrial fibrillation: an economic evaluation of the RAAFT pilot study", J Cardiovasc Electrophysiol, 20(1), pp. 7 ­ 12.

79. Kistler P., Sanders P., Fynn S., et al. (2004), "Electrophysiologic and electro­anatomic changes in the human atrium associated with age", J Am Coll Cardiol, 44(1), pp. 109 ­ 116.

80. Kritz H., Schmid P., Sinzinger H. (1995), "Passive smoking and cardiovascular risk ", Arch Intern Med, 155(18), pp. 1942 ­ 1948.

81. Lall S., Melby S., Voeller R., et al. (2007), "The effect of ablation technology on surgical outcomes after the Cox­maze procedure: a propensity analysis", The Journal of thoracic and cardiovascular surgery, 133(2), pp. 389 ­ 396.

82. Lamas G., Lee K., Sweeney M., et al. (2000), "The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients", Am Heart J, 140(4), pp. 541 ­

551.

83. Lee J., Kalman J. (2013), "Sinus node dysfunction and atrial fibrillation: two sides of the same coin?", Europace, 15(2), pp. 161 ­ 162.

84. Lip Y., Golding D., Nazir M., et al. (1997), "A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project", Br J Gen Pract, 47, pp. 285­289.

85. Lip Y., LI H. (2001), "Paroxysmal atrial Fibrillation", QJ Med, 94, pp. 665 ­ 678.

86. Lloyd­Jones D., Wang T., Leip E., et al. (2004), "Lifetime risk for

development of atrial fibrillation: the Framingham Heart Study",

Circulation, 110, pp. 1042 ­ 1046.

87. Mandapati R, Skanes A, Chen J., et al. (2000), "Stable micro­ reentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart", Circulation, 101(2), pp. 194 ­ 199.

88. Markides V, Shilling RJ, Ho SY et al. (2003 ), "Characterization of the left atrial activation in the intact human heart", Circulation, 107, pp. 733 ­ 739

89. Markides V., Schilling R. (2003), "Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment.", Heart, 89(8), pp. 939 ­ 943.

90. Masateru T., Takahashi A., Kuwahara T., et al. (2014), "Long­Term Follow­Up After Catheter Ablation of Paroxysmal Atrial Fibrillation: The Incidence of Recurrence and Progression of Atrial Fibrillation", Circ Arrhythm Electrophysiol, 7, pp. 267 ­ 273.

91. Miao C., Yin X., Dong J., et al. (2012), "Catheter ablation of persistent atrial fibrillation with and without a history of paroxysmal atrial fibrillation", Chinese medical journal, 125(6), pp. 1175 ­ 1178.

92. Miyazaki S., Kuwahara T., Takahashi A., (2012), "Impact of the preprocedural frequency of paroxysmal atrial fibrillation on the clinical outcome after catheter ablation", PACE, 35(10), pp. 1236 ­ 1241.

93. Mulder A., Wijffels M., Wever E., et al. (2012), "Freedom from paroxysmal atrial fibrillation after successful pulmonary vein isolation with pulmonary vein ablation catheter­phased radiofrequency energy: 2­year follow­up and predictors of failure", Europace, 14(6), pp. 818­

825.

94. Murgatroyd F., Klein G, Yee R, et al. (2006), Handbook of Cardiac Electrophysiology. Re Medica publication.

95. Naccarelli G., Varker H., Lin J., et al. (2009), "Increasing prevalence of atrial fibrillation and flutter in the United States", Am J Cardiol, 104, pp. 1534 ­ 1539.

96. Nademanee K., McKenzie J., Kosar E., et al. (2004), "A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiological substrate", J Am Coll Cardiol, 43(11), pp. 2044 ­ 2053.

97. Nakao K., Seto S., Ueyama C., et al. (2002), "Extended distribution of prolonged and fractionated right atrial electrograms predicts development of chronic atrial fibrillation in patients with idiopathic paroxysmal atrial fibrillation", J Cardiovasc Electrophysiol, 13(10), pp. 996 ­ 1002.

98. O’Donnell D., Furniss S. (2002), "Paroxysmal cycle length shortening in the pulmonary veins during atrial fibrillation correlates with arrhythmogenic triggering foci in sinus rhythm", J Cardiovasc Electrophysiol, 13(2), pp. 124 ­ 128.

99. Olshansky B., Rosenfeld L., Warner A., et al. (2004), "The Atrial Fibrillation Follow­up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation", J Am Coll Cardiol, 43(7), pp. 1201 ­ 1208.

100. Oral H., Ozaydin M., Chugh A., et al. (2003), "Role of the coronary sinus in maintenance of atrial fibrillation", Cardiovasc Electrophysiol

14(12), pp. 1329 ­ 1336.

101. Oral H., Sharf C., Chugh A., et al. (2003), "Catheter ablation for paroxysmal atrial fibrillation. Segmental pulmonary vein ostial ablation versus left atrial ablation. ", Circulation, 108, pp. 2355 ­ 2360.

102. Oral H., Aman C., Good E., et al. (2006), "A Tailored Approach to Catheter Ablation of Paroxysmal Atrial Fibrillation", Circulation, 113, pp. 1824 ­ 1831.

103. Oral H., Chugh A., Lemola K., et al. (2004), "Noninducibility of Atrial Fibrillation as an End Point of Left Atrial Circumferential Ablation for Paroxysmal Atrial Fibrillation: A Randomized Study", Circulation, 110, pp. 2797 ­ 2801.

104. Oral H., Knight B., Tada H., et al. (2002), "Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation", Circulation, 105, pp. 1077 ­ 1081.

105. Ouyang F., Bansch D., Ernst S., et al. (2004), "Complete isolation of left atrium surrounding the pulmonary veins. New insights from the double­lasso technique in paroxysmal atrial fibrillation", Circulation, 110, pp. 2090 ­ 2096.

106. Pappone C., Augello G., Sala S., et al. (2006), "A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study", J Am Coll Cardiol, 48, pp. 2340 ­ 2347.

107. Pappone C., Santinelli V., Manguso F., et al. (2004), "Pulmonary vein denervation enhances long­term benefit after circumferential ablation for paroxysmal atrial fibrillation", Circulation, 109, pp. 327 ­ 334.

108. Pappone C., Oreto G., Lamberti F., et al. (1999), "Catheter Ablation

of Paroxysmal Atrial Fibrillation Using a 3D Mapping System",

Circulation, 100, pp. 1203 ­ 1208.

109. Pappone C., Rosanio S., Oreto G., et al. (2000), "Circumferential Radiofrequency Ablation of Pulmonary Vein Ostia : A New Anatomic Approach for Curing Atrial Fibrillation", Circulation, 102, pp. 2619 ­ 2628.

110. Park Y., Choi J., Lim H., et al. (2012), "Is pursuit of termination of atrial fibrillation during catheter ablation of great value in patients with longstanding persistent atrial fibrillation?", Journal of cardiovascular electrophysiology, 23(10), pp. 1051 ­ 1058.

111. Piccini J., Lopes R., Kong M., et al. (2009), "Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta­analysis of randomized, controlled trials", Circ Arrhythm Electrophysiol, 2, pp. 626 ­ 633.

112. Ramanna H., Hauer R., Wittkampf F., et al. (2000), "Identification of the substrate of atrial vulnerability in patients with idiopathic atrial fibrillation ", Circulation, 101, pp. 995 ­ 1001.

113. Samuel W., Anne B., Craig T., et al. (2011), "2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)", JACC, 57(10), pp. 1­20.

114. Sanchez D., Cabrera J., Climent V., et al. (2005), "Anatomic relations between the esophagus and left atrium and relevance for ablation of atrial fibrillation", Circulation, 112, pp. 1400 ­ 1405.

115. Scanavacca M., Pisani C., Hachul D., et al. (2006), "Selective atrial

vagal denervation guided by evoked vagal reflex to treat patients with paroxysmal atrial fibrillation", Circulation, 114, pp. 876 ­ 885.

116. Schmitt C., Deisenhofer I. (2008), Catheter ablation of Cardiac Arhythmias Catheter ablation of atrial fibrillation, Wurzburg Steinkopff Verlag Darmstadt.

117. Schmitt C., Nderepepa G., Weber S., et al. (2002), "Biatrial multisite mapping of atrial premature complexes triggering onset of atrial fibrillation", J Am Coll Cardiol, 89, pp. 1381 ­ 1387.

118. Schotten U., Verheule S., Kirchhof P., et al. (2011), "Patho­ physiological mechanisms of atrial fibrillation a translational appraisal.", Physiol Rev 91(4), pp. 265 ­ 325.

119. Seow S., Lim T., Koay C., et al. (2007), "Efficacy and late recurrences with wide electrical pulmonary vein isolation for persistent and permanent atrial fibrillation.", Europace, 9(12), pp. 1129 ­ 1133.

120. Stabile G., Bertaglia E., Senatore G., et al. (2006), "Catheter ablation treatment in patients with drug­refractory atrial fibrillation: a prospective, multi­centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study)", Eur Heart J, 27(2), pp. 216 ­ 221.

121. Takahashi A., Iesaka Y., Takahashi Y., et al. (2002), "Electrical Connections Between Pulmonary Veins: Implication for Ostial Ablation of Pulmonary Veins in Patients With Paroxysmal Atrial Fibrillation ", Circulation, 105, pp. 2998 ­ 3003.

122. Thomas S., Lim T., McCall R., et al. (2007), "Electrical isolation of the posterior left atrial wall and pulmonary veins for atrial fibrillation:

feasibility of and rationale for a single­ring approach ", Heart Rhythm

4(6), pp. 722 ­ 730.

123. Traykov V., Pap R., Gingl Z., et al. (2013), "Role of triggering pulmonary veins in the maintenance of sustained paroxysmal atrial fibrillation.", Pacing Clin Electrophysiol, 36(7), pp. 845 ­ 854.

124. Uhm J., Mun H., Wi J., et al. (2013), "Prolonged atrial effective refractory periods in atrial fibrillation patients associated with structural heart disease or sinus node dysfunction compared with lone atrial fibrillation", Pacing Clin Electrophysiol, 36(2), pp. 163 ­ 171.

125. Van Gelder I., Groenveld H., Crijns H., et al. (2010), "Lenient versus strict rate control in patients with atrial fibrillation", N Engl J Med, 362, pp. 1363 ­ 1373.

126. Veinot J., Harrity P., Gentile F., et al. (1997), "Anatomy of the normal left atrial appendage. A quantitative study of age­related changes in 500 autopsy hearts: implications for echocardiographic examination", Circulation, 96, pp. 3112 ­ 3115.

127. Watson T., Shantsila E., (2009), "Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited", Lancet,373, pp. 155 ­ 166.

128. Wazni O., Marrouche N., Martin D., et al. (2005), "Radiofrequency ablation vs antiarrhythmic drugs as first­line treatment of symptomatic atrial fibrillation: a randomized trial", JAMA, 293, pp. 2634 ­ 2640.

129. Weerasooriya R., Davis M., Powell A., et al. (2003), "The Australian intervention randomized control of rate in atrial fibrillation trial (AIR­ CRAFT)", J Am Coll Cardiol, 41, pp. 1697 ­ 1702.

130. Wilber D., Pappone C., Neuzil P., et al. (2010), "Comparison of